Phase II Trial of CHOP Plus Rituximab in Patients With HIV-Associated Non-Hodgkin’s Lymphoma
- 9 February 2007
- journal article
- other
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 25 (6) , e7
- https://doi.org/10.1200/jco.2006.09.0407
Abstract
No abstract availableThis publication has 3 references indexed in Scilit:
- Phase II Trial of CHOP Plus Rituximab in Patients With HIV-Associated Non-Hodgkin's LymphomaJournal of Clinical Oncology, 2006
- Rituximab does not improve clinical outcome in a randomized phase 3 trial of CHOP with or without rituximab in patients with HIV-associated non-Hodgkin lymphoma: AIDS-Malignancies Consortium Trial 010Blood, 2005
- Rituximab plus infusional cyclophosphamide, doxorubicin, and etoposide in HIV-associated non-Hodgkin lymphoma: pooled results from 3 phase 2 trialsBlood, 2005